SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
